One of the first actions by GSK's recently appointed chief scientific officer, Tony Wood, has been to expand a partnership with Tempus aimed at improving the big pharma's R&D productivity, starting ...

FOX Business host Charles Payne spotlights a massive investment opportunity he says could be worth trillions on ‘Making Money.’ 'The Big Money Show' panel discusses artificial intelligence being ...